Second Sight Medical Products Inc(NASDAQ:VANI) 
Vivani Medical, Inc. develops and commercializes drug and device implants to treat patients with chronic diseases with unmet medical need. Its lead product candidate is NPM-119, a GLP-1 receptor agonist under development to treat patients with Type 2 diabetes. The company is based in Sylmar, Califor...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.99
H 1.00
L 0.91
C 0.96
V 264,327
10EMA 0.96
20EMA 0.96
60EMA 0.96
120EMA 0.96
250EMA 0.96